Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aliberti

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 4, 2020
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemiaA Bandera, S Aliberti, R Gualtierotti, et al.
Infection and Immunity|March 2, 2011
Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1Fredy R S Gutierrez, Flávia S Mariano, Carlo J F Oliveira, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 28, 2024
TB outpatient care in a high-income, low-incidence countryN Riccardi, C Monari, R M Antonello, et al.
Cancer|May 20, 2009
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patientsM Berger, Berger Massimo, G Grignani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2007
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumoursR Luksch, G Grignani, F Fagioli, et al.
Thorax|August 13, 2016
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohortsM J McDonnell, S Aliberti, P C Goeminne, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
Infection|October 2, 2015
Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory responseJ M Bordon, R Fernandez-Botran, T L Wiemken, et al.
ESMO Open|February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group networkG G Baldi, A M Frezza, C Biagioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 4, 2020
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemiaA Bandera, S Aliberti, R Gualtierotti, et al.
Infection and Immunity|March 2, 2011
Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1Fredy R S Gutierrez, Flávia S Mariano, Carlo J F Oliveira, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 28, 2024
TB outpatient care in a high-income, low-incidence countryN Riccardi, C Monari, R M Antonello, et al.
Cancer|May 20, 2009
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patientsM Berger, Berger Massimo, G Grignani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2007
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumoursR Luksch, G Grignani, F Fagioli, et al.
Thorax|August 13, 2016
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohortsM J McDonnell, S Aliberti, P C Goeminne, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
Infection|October 2, 2015
Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory responseJ M Bordon, R Fernandez-Botran, T L Wiemken, et al.
ESMO Open|February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group networkG G Baldi, A M Frezza, C Biagioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Pageof 5